Adenocarcinoma of unknown primary: retrospective analysis of chemosensitivity of 313 freshly explanted tumors in a tumor cloning system-Reference-Cited by-同舟云学术

Adenocarcinoma of unknown primary: retrospective analysis of chemosensitivity of 313 freshly explanted tumors in a tumor cloning system

Published:1995-03 Issue:1 Volume:13 Page:43-49
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Hanauske Axel -R.,Clark Gary M.,Von Hoff Daniel D.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF02614219.pdf

Reference42 articles.

1. Greco FA, Hainsworth JD: Tumors of unknown origin. Ca: A Cancer Journal For Clinicians 42:96–115, 1992

2. Altman E, Cadman E: An analysis of 1539 patients with cancer of unknown primary site. Cancer 57:120–124, 1986

3. Hainsworth JD, Greco FA: Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary tumor site. Semin Oncol 20:279–286, 1993

4. Ilson DH, Motzer Rj, Rodriguez E, Chaganti RS, Bosl GJ: Genetic analysis in the diagnosis of neoplasms of unknown primary tumor site. Semin Oncol 20:229–237, 1993

5. Garrow GC, Greco FA, Hainsworth JD: Poorly differentiated neuroendocrine carcinoma of unknown primary tumor site. Semin Oncol 30:287–291, 1993

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-Infiltrating Immune Cells: Triggers for Tumor Capsule Disruption and Tumor Progression?;International Journal of Medical Sciences;2013

2. Results of a Phase II Study of Weekly Paclitaxel Plus Carboplatin in Advanced Carcinoma of Unknown Primary Origin: A Reasonable Regimen for the Community-Based Clinic?;Cancer Investigation;2007-01

3. Adenocarcinoma of Unknown Primary Site;The Korean Journal of Internal Medicine;2002-12-31

4. Carcinoma of Unknown Primary;Current Cancer Therapeutics;2001

5. Carboplatin Plus Paclitaxel in Unknown Primary Carcinoma: A Phase II Hellenic Cooperative Oncology Group Study;Journal of Clinical Oncology;2000-09-17